EC Pharmaceutical Strategy is an official public source that HealthSignal monitors for Pharmaceuticals. The most recent updates we have tracked from it are listed below, each normalised into our index and linked back to the original publication on the source's own website.
News announcement 24 June 2026 Eudralex Volume 4: Reference and Retention Samples (revised, applicable as of 24 September 2026) 1 min read
EC Pharmaceutical StrategyNews announcement6 June 2025Commission grants conditional authorisation medicine for treatment of Duchenne muscular dystrophy1 min read
EC Pharmaceutical Strategy